Study shows Tri-Low extract of amla’s efficacy in reducing dyslipidemia
date:Mar 26, 2019
A newly-published study demonstrates the efficacy and safety of Tri-Low full extract of amla (Phyllanthus emblica), the Indian gooseberry, in alleviating dyslipidemia, a leading contributing risk factor to the development of atherosclerosis.

The amla extract has shown significant potential in reducing total cholesterol and triglyceride levels and in stimulating a more favorable balance of lipid ratios.

These results confirm Tri-Lows functionality as a superior, clean-label cardiac health supp
1/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/31 11:10